These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 16737349)

  • 1. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.
    Fretheim A; Aaserud M; Oxman AD
    PLoS Med; 2006 Jun; 3(6):e216. PubMed ID: 16737349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational prescribing in primary care (RaPP): a cluster randomized trial of a tailored intervention.
    Fretheim A; Oxman AD; Håvelsrud K; Treweek S; Kristoffersen DT; Bjørndal A
    PLoS Med; 2006 Jun; 3(6):e134. PubMed ID: 16737346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential savings of using thiazides as the first choice antihypertensive drug: cost-minimisation analysis.
    Fretheim A; Aaserud M; Oxman AD
    BMC Health Serv Res; 2003 Sep; 3(1):18. PubMed ID: 12959644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Prescribing in Primary Care (RaPP-trial). A randomised trial of a tailored intervention to improve prescribing of antihypertensive and cholesterol-lowering drugs in general practice [ISRCTN48751230].
    Fretheim A; Oxman AD; Treweek S; Bjørndal A
    BMC Health Serv Res; 2003 Feb; 3(1):5. PubMed ID: 12657163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of mandatory prescribing of thiazides for newly treated, uncomplicated hypertension: interrupted time-series analysis.
    Fretheim A; Håvelsrud K; MacLennan G; Kristoffersen DT; Oxman AD
    PLoS Med; 2007 Jul; 4(7):e232. PubMed ID: 17622192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International variation in prescribing antihypertensive drugs: its extent and possible explanations.
    Fretheim A; Oxman AD
    BMC Health Serv Res; 2005 Mar; 5(1):21. PubMed ID: 15762983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving prescribing practices in primary care. A randomised trial and economic analysis of a multicomponent intervention showed small, but important, gains.
    Del Mar C
    PLoS Med; 2006 Jun; 3(6):e229. PubMed ID: 16729845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost savings associated with improving appropriate and reducing inappropriate preventive care: cost-consequences analysis.
    Hogg W; Baskerville N; Lemelin J
    BMC Health Serv Res; 2005 Mar; 5(1):20. PubMed ID: 15755330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting feasibility and acceptability of a practice-based educational intervention to support evidence-based prescribing: a qualitative study.
    Watkins C; Timm A; Gooberman-Hill R; Harvey I; Haines A; Donovan J
    Fam Pract; 2004 Dec; 21(6):661-9. PubMed ID: 15528289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report on financing the new model of family medicine.
    Spann SJ;
    Ann Fam Med; 2004 Dec; 2 Suppl 3(Suppl 3):S1-21. PubMed ID: 15654084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of prescription practices and of the rational use of medicines in Niger].
    Mallet HP; Njikam A; Scouflaire SM
    Sante; 2001; 11(3):185-93. PubMed ID: 11641083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of changes in antihypertensive drug utilisation following primary care educational interventions.
    Horn FE; Mandryk JA; Mackson JM; Wutzke SE; Weekes LM; Hyndman RJ
    Pharmacoepidemiol Drug Saf; 2007 Mar; 16(3):297-308. PubMed ID: 16634120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the effect of a countywide protected learning time scheme on prescribing rates of ramipril: interrupted time series study.
    Siriwardena AN; Fairchild P; Gibson S; Sach T; Dewey M
    Fam Pract; 2007 Feb; 24(1):26-33. PubMed ID: 17052988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial.
    Simon SR; Majumdar SR; Prosser LA; Salem-Schatz S; Warner C; Kleinman K; Miroshnik I; Soumerai SB
    Am J Med; 2005 May; 118(5):521-8. PubMed ID: 15866255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving cost-effectiveness of hypertension management at a community health centre.
    Edwards PR; Lunt DW; Fehrsen GS; Lombard CJ; Steyn K
    S Afr Med J; 1998 May; 88(5):549-54. PubMed ID: 9638122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current trends in treatment of obesity in Karachi and possibilities of cost minimization.
    Hussain MI; Naqvi BS
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):765-72. PubMed ID: 25796152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice.
    Freemantle N; Nazareth I; Eccles M; Wood J; Haines A;
    Br J Gen Pract; 2002 Apr; 52(477):290-5. PubMed ID: 11942445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated annual direct expenditures in the United States as a result of inappropriate hypertension treatment according to national treatment guidelines.
    Balu S
    Clin Ther; 2009 Jul; 31(7):1581-94. PubMed ID: 19695408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial.
    Nazareth I; Freemantle N; Duggan C; Mason J; Haines A
    J Health Serv Res Policy; 2002 Oct; 7(4):230-8. PubMed ID: 12425782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.